Published in Am J Physiol Renal Physiol on January 16, 2007
New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides (2011) 1.32
Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus. Hypertension (2009) 1.30
Novel roles of nuclear angiotensin receptors and signaling mechanisms. Am J Physiol Regul Integr Comp Physiol (2011) 1.26
Reactive oxygen species and dopamine receptor function in essential hypertension. Clin Exp Hypertens (2009) 1.02
Angiotensin II-dependent superoxide: effects on hypertension and vascular dysfunction. Hypertension (2008) 1.01
1,25-dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity. PLoS One (2012) 0.89
Renovascular hypertension leads to DNA damage and apoptosis in bone marrow cells. DNA Cell Biol (2013) 0.82
DNA damage and augmented oxidative stress in bone marrow mononuclear cells from Angiotensin-dependent hypertensive mice. Int J Hypertens (2013) 0.82
Aldosterone activates transcription factor Nrf2 in kidney cells both in vitro and in vivo. Antioxid Redox Signal (2014) 0.80
Genomic damage in endstage renal disease-contribution of uremic toxins. Toxins (Basel) (2010) 0.79
Increased lymphocyte micronucleus frequency in early pregnancy is associated prospectively with pre-eclampsia and/or intrauterine growth restriction. Mutagenesis (2010) 0.77
Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors. PLoS One (2014) 0.75
Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res (2006) 2.07
Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation. J Hepatol (2002) 1.76
Serum carboxymethyllysine predicts mortality in hemodialysis patients. Am J Kidney Dis (2006) 1.59
The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats. Kidney Int (2011) 1.56
Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J Hepatol (2004) 1.55
Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease. Nephrol Dial Transplant (2011) 1.47
Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients. Clin Chem Lab Med (2005) 1.23
Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro. Stem Cells (2006) 1.14
Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro. Diabetes Metab Res Rev (2008) 1.05
The HUman MicroNucleus project on eXfoLiated buccal cells (HUMN(XL)): the role of life-style, host factors, occupational exposures, health status, and assay protocol. Mutat Res (2011) 1.02
SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans. Eur J Immunol (2008) 1.01
Sodium arsenite modulates histone acetylation, histone deacetylase activity and HMGN protein dynamics in human cells. Chromosoma (2007) 0.99
Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats. FASEB J (2010) 0.97
Renal disease in obesity: the need for greater attention. J Ren Nutr (2006) 0.96
Renal, vascular and cardiac fibrosis in rats exposed to passive smoking and industrial dust fibre amosite. J Cell Mol Med (2008) 0.96
Antioxidant and anti-protease activities of diazepinomicin from the sponge-associated Micromonospora strain RV115. Mar Drugs (2012) 0.95
Evaluation of the reticulocyte micronucleus assay in patients treated with radioiodine for thyroid cancer. Mutat Res (2005) 0.93
Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians. Mol Nutr Food Res (2006) 0.92
Effects of a diet rich in advanced glycation end products in the rat remnant kidney model. Am J Kidney Dis (2003) 0.91
Genotoxicity of advanced glycation end products in mammalian cells. Cancer Lett (2003) 0.91
Plasma advanced glycation end products are decreased in obese children compared with lean controls. Int J Pediatr Obes (2009) 0.89
Patulin: Mechanism of genotoxicity. Food Chem Toxicol (2012) 0.89
Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder? Environ Health Perspect (2007) 0.89
The contribution of Rudolf Virchow to the concept of inflammation: what is still of importance? J Nephrol (2006) 0.89
Micronucleus frequency in buccal mucosa cells of mobile phone users. Toxicol Lett (2009) 0.88
Terahertz radiation at 0.380 THz and 2.520 THz does not lead to DNA damage in skin cells in vitro. Radiat Res (2012) 0.88
Aldosterone induces oxidative stress, oxidative DNA damage and NF-κB-activation in kidney tubule cells. Mol Carcinog (2010) 0.87
Dietary bread crust advanced glycation end products bind to the receptor for AGEs in HEK-293 kidney cells but are rapidly excreted after oral administration to healthy and subtotally nephrectomized rats. Ann N Y Acad Sci (2005) 0.87
Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.86
Inflammation and gene expression in the rat lung after instillation of silica nanoparticles: effect of size, dispersion medium and particle surface charge. Toxicol Lett (2014) 0.85
Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci (2012) 0.85
Angiotensin II induces DNA damage in the kidney. Cancer Res (2008) 0.85
Terahertz electromagnetic fields (0.106 THz) do not induce manifest genomic damage in vitro. PLoS One (2012) 0.85
Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis. Atherosclerosis (2007) 0.84
Deviation from additivity in mixture toxicity: relevance of nonlinear dose-response relationships and cell line differences in genotoxicity assays with combinations of chemical mutagens and gamma-radiation. Environ Health Perspect (2002) 0.84
Angiotensin II induces DNA damage via AT1 receptor and NADPH oxidase isoform Nox4. Mutagenesis (2012) 0.83
The selective TP receptor antagonist, S18886 (terutroban), attenuates renal damage in the double transgenic rat model of hypertension. Am J Nephrol (2007) 0.83
Renal effects of oral maillard reaction product load in the form of bread crusts in healthy and subtotally nephrectomized rats. Ann N Y Acad Sci (2005) 0.83
Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis. Nephrol Dial Transplant (2005) 0.82
Genotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors. Ann N Y Acad Sci (2005) 0.82
Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation. Am J Nephrol (2002) 0.82
Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation. Nephrol Dial Transplant (2008) 0.82
N-methyl-2-pyridone-5-carboxamide: a novel uremic toxin? Kidney Int Suppl (2003) 0.82
Renal effects of S18886 (Terutroban), a TP receptor antagonist, in an experimental model of type 2 diabetes. Diabetes (2007) 0.82
Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system. Am J Nephrol (2008) 0.82
Georg Ganter--a pioneer of peritoneal dialysis and his tragic academic demise at the hand of the Nazi regime. J Nephrol (2004) 0.81
Aldosterone increases kidney tubule cell oxidants through calcium-mediated activation of NADPH oxidase and nitric oxide synthase. Free Radic Biol Med (2011) 0.81
Effect of different hemodialysis regimens on genomic damage in end-stage renal failure. Semin Nephrol (2006) 0.81
Is implanto-prosthodontic treatment available for haemodialysis patients? Nephrol Dial Transplant (2007) 0.81
Aldosterone activates transcription factor Nrf2 in kidney cells both in vitro and in vivo. Antioxid Redox Signal (2014) 0.80
The role of the dopamine transporter in dopamine-induced DNA damage. Brain Pathol (2010) 0.80
High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease. Nephrol Dial Transplant (2008) 0.80
Advanced oxidation protein products and advanced glycation end products in children and adolescents with chronic renal insufficiency. J Ren Nutr (2012) 0.80
Atorvastatin attenuates oxidative stress in patients with chronic kidney disease. Med Sci Monit (2010) 0.80
Influence of altered apoptosis in human lymphoblastoid cell lines on micronucleus frequency. Toxicol Lett (2004) 0.80
The contribution of neuronal-glial-endothelial-epithelial interactions to colon carcinogenesis. Cell Mol Life Sci (2014) 0.79
No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy. Toxicol Lett (2008) 0.79
[Respiratory diseases and genotoxicity in tobacco smoke exposed children]. Laryngorhinootologie (2002) 0.79
Antiproliferative effects of fluoxetine on colon cancer cells and in a colonic carcinogen mouse model. PLoS One (2012) 0.79
Genomic damage in endstage renal disease-contribution of uremic toxins. Toxins (Basel) (2010) 0.79
Different types of combination effects for the induction of micronuclei in mouse lymphoma cells by binary mixtures of the genotoxic agents MMS, MNU, and genistein. Toxicol Sci (2005) 0.79
Accumulation of poly(ADP-ribose) polymerase inhibitors in children with chronic renal failure. Pediatr Nephrol (2006) 0.79
Insulin mediated DNA damage in mammalian colon cells and human lymphocytes in vitro. Mutat Res (2013) 0.78
Renal research in 19th century Germany. Am J Kidney Dis (2010) 0.78
Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease. Am J Hypertens (2005) 0.78
Studies on cytotoxic and genotoxic effects of N-hydroxypyridine-2-thione (Omadine) in L5178Y mouse lymphoma cells. Toxicol Lett (2002) 0.78
The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma. Mol Cell Biochem (2004) 0.78
Increased protein glycation in cirrhosis and therapeutic strategies to prevent it. Ann N Y Acad Sci (2005) 0.78
The role of Kupffer cells in the hepatic response to silver nanoparticles. Nanotoxicology (2013) 0.78
Behaviour and hormonal status in healthy rats on a diet rich in Maillard reaction products with or without solvent extractable aroma compounds. Physiol Behav (2011) 0.78
Insulin-mediated oxidative stress and DNA damage in LLC-PK1 pig kidney cell line, female rat primary kidney cells, and male ZDF rat kidneys in vivo. Endocrinology (2013) 0.78
Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: potential importance of dialysate quality. Nephrol Dial Transplant (2002) 0.78
No increased chromosomal damage in L-DOPA-treated patients with Parkinson's disease: a pilot study. J Neural Transm (Vienna) (2010) 0.78
Hyperthermia-induced micronucleus formation in a human keratinocyte cell line. Mutat Res (2012) 0.78
Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients. Scand J Urol Nephrol (2005) 0.77
Glucagon-like peptide 2 in colon carcinogenesis: possible target for anti-cancer therapy? Pharmacol Ther (2013) 0.77
Analysis of in vitro chemoprevention of genotoxic damage by phytochemicals, as single agents or as combinations. Mutat Res (2012) 0.77
Antigenotoxic effects of the phytoestrogen pelargonidin chloride and the polyphenol chlorogenic acid. Mol Nutr Food Res (2007) 0.77
Spironolactone attenuates oxidative stress in patients with chronic kidney disease. Hypertension (2008) 0.77
Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine. PLoS One (2013) 0.77
Prevention of aneuploidy by S-adenosyl-methionine in human cells treated with sodium arsenite. Mutat Res (2006) 0.77
Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis. Scand J Urol Nephrol (2004) 0.77
Functional hyperhomocysteinemia in healthy vegetarians: no association with advanced glycation end products, markers of protein oxidation, or lipid peroxidation after correction with vitamin B(12). Clin Chem (2003) 0.77
New approaches for the treatment of genomic damage in end-stage renal disease. J Ren Nutr (2008) 0.77